Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States.

Cheng, Ching-An; Jiang, Ai-Lei; Liu, Yu-Ru; Chang, Lin-Chau

Cheng, Ching-An; Jiang, Ai-Lei; Liu, Yu-Ru; Chang, Lin-Chau.

Afiliación

Cheng CA; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jiang AL; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Liu YR; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chang LC; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.

Clin Pharmacol Ther ; 114(6): 1274-1284, 2023 12.

Article en En | MEDLINE | ID: mdl-37634125

Asunto(s)

Antineoplásicos; Biosimilares Farmacéuticos; Estados Unidos; Humanos; Biosimilares Farmacéuticos/efectos adversos; Anticuerpos Monoclonales/efectos adversos; United States Food and Drug Administration; Aprobación de Drogas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Antineoplásicos Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google